Research Enterprise Feature

IU-based startup Arrhythmotech awarded $1.47M NIH grant to study atrial fibrillation, nerve activity

A life sciences company based on Indiana University technology has received a two-year, $1,472,476 grant from the National Institutes of Health to help researchers determine if nerve activity is associated with a common heart rhythm disorder.

Officials at Arrhythmotech LLC will use the STTR Phase II grant on new methods to study patients who are affected by atrial fibrillation. Atrial fibrillation causes the heart's upper chambers to contract irregularly instead of working together with the lower chambers.

Read more